WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients (Q42465743)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

ChEBI release 2020-05-28

skeletal muscle cell

1 reference

based on heuristic

inferred from title

author name string

Bouzakri K

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Roques M

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Debard C

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Berbe V

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Rieusset J

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Laville M

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Vidal H

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1314-1323

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Role of insulin resistance in the pathogenesis of NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Insulin action and insulin resistance in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

The expression of the p85alpha subunit of phosphatidylinositol 3-kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Regulation of p85alpha phosphatidylinositol-3-kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Cellular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Muscle triglyceride and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1428-1

21 January 2018

Identifiers

10.1007/S00125-004-1428-1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

reason for deprecated rank

incorrect identifier value

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42465743&oldid=2205415094"